학술논문

A phase II study of S-1 and cisplatin with concurrent thoracic radiotherapy followed by durvalumab for unresectable, locally advanced non-small-cell lung cancer in Japan (SAMURAI study): primary analysis
Document Type
Article
Source
In: Therapeutic Advances in Medical Oncology. (Therapeutic Advances in Medical Oncology, January-December 2022, 14)
Subject
Language
English
ISSN
17588359
17588340